RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No follow throughBio have you heard of the HemAcure Project? Just happens that they are using the cell pouch for hemophilia. Take a look at the NR last May had some great preclinical results and it will likely be progressing to the clinic in the near future and when you speak of being short on cash this is grant money. Would definitely be nice to see us entering the clinic for Hemophilia Q1 2021 would make SGTX valuation gap even more obviouse/ridiculous..
"These promising results of the HemAcure consortium are paving the way for future human clinical testing in hemophilia A patients using Sernova's technologies transplanted with corrected FVIII cells developed by this prestigious international team. This initiative continues to support the value of collaborative efforts involving Sernova's regenerative medicine technologies in both diabetes and now rare diseases such as hemophilia A," said Dr. Philip Toleikis, President and CEO of Sernova Corp.
https://stockhouse.com/news/press-releases/2020/05/19/sernova-highlights-achievements-of-the-hemacure-hemophilia-cell-therapy-program